{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T18:38:20Z","timestamp":1780943900917,"version":"3.54.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2018,10,2]],"date-time":"2018-10-02T00:00:00Z","timestamp":1538438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>\u2003<\/jats:title>\n                  <jats:p>Bisphosphonate use has been associated with atypical femoral fractures (AFFs), defined by the American Society of Bone and Mineral Research (ASBMR) Task Force criteria, which currently exclude periprosthetic fractures. The objectives of this study were to establish the prevalence of atypical periprosthetic femoral fractures (APFFs) in patients with hip and knee arthroplasties and to determine the clinical and radiological risk factors associated with these fractures. We performed a retrospective radiological review of all femoral fractures between January 1, 2006, and March 31, 2015, in Quebec City, Canada. Patients who sustained a periprosthetic femoral fracture (PFF) were identified and included in this study. We used the ASBMR Task Force criteria to identify atypical fractures and establish their prevalence. Data from medical records and radiological assessments of the femoral anatomy, the characteristics of the fracture, and the positioning of the prosthesis were collected. The prevalence of APFFs among PFFs was 8.3% (11\/133). A strong association with bisphosphonates (p\u2009=\u20090.007) was observed, as well as an increased risk of APFFs among alendronate users compared to risedronate users (p\u2009=\u20090.04). A transverse fracture (p &amp;lt; 0.0001), a periosteal thickening of the lateral cortex at the fracture (p &amp;lt; 0.0001), a unicortical fracture (p\u2009=\u20090.02), and prodromal symptoms (p\u2009=\u20090.03) were associated with APFFs. The type of implant, its positioning, and the femoral geometry did not appear to be risk factors for APFFs compared to PFFs. \u00a9 2018 American Society for Bone and Mineral Research.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1002\/jbmr.3584","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T05:03:25Z","timestamp":1538543005000},"page":"83-92","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Prevalence and Characteristics of Atypical Periprosthetic Femoral Fractures"],"prefix":"10.1093","volume":"34","author":[{"given":"Jean-Thomas","family":"Leclerc","sequence":"first","affiliation":[{"name":"Department of Orthopedic SurgeryCentre Hospitalier Universitaire (CHU) de Qu\u00e9bec\u2013Universit\u00e9 LavalQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"La\u00ebtitia","family":"Michou","sequence":"additional","affiliation":[{"name":"Centre de recherche Fonds de la recherche du Qu\u00e9bec en sant\u00e9 (FRQS) du Centre Hospitalier Universitaire (CHU) de Qu\u00e9becQuebecQCCanada"},{"name":"Division of RheumatologyDepartment of MedicineCentre Hospitalier Universitaire (CHU) de Qu\u00e9bec\u2013Universit\u00e9 LavalQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vaillancourt","sequence":"additional","affiliation":[{"name":"Department of MedicineUniversit\u00e9 LavalQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Pelet","sequence":"additional","affiliation":[{"name":"Centre de recherche Fonds de la recherche du Qu\u00e9bec en sant\u00e9 (FRQS) du Centre Hospitalier Universitaire (CHU) de Qu\u00e9becQuebecQCCanada"},{"name":"Department of Orthopedic SurgeryCentre Hospitalier Universitaire (CHU) de Qu\u00e9bec\u2013Universit\u00e9 LavalQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simonyan","sequence":"additional","affiliation":[{"name":"Clinical and Evaluative Research PlatformCentre Hospitalier Universitaire (CHU) de Qu\u00e9bec\u2013Universit\u00e9 Laval Research CentreQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne L","family":"Belzile","sequence":"additional","affiliation":[{"name":"Centre de recherche Fonds de la recherche du Qu\u00e9bec en sant\u00e9 (FRQS) du Centre Hospitalier Universitaire (CHU) de Qu\u00e9becQuebecQCCanada"},{"name":"Department of Orthopedic SurgeryCentre Hospitalier Universitaire (CHU) de Qu\u00e9bec\u2013Universit\u00e9 LavalQuebecQCCanada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,2]]},"reference":[{"issue":"8","key":"2024021014530195000_jbmr3584-bib-0001","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study","volume":"20","author":"Lenart","year":"2009","journal-title":"Osteoporos Int"},{"issue":"3","key":"2024021014530195000_jbmr3584-bib-0002","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2024021014530195000_jbmr3584-bib-0003","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jbmr.2748","article-title":"Incidence and characteristics of atypical femoral fractures: clinical and geometrical data","volume":"31","author":"Mahjoub","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2024021014530195000_jbmr3584-bib-0005","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1007\/s11999-015-4263-4","article-title":"Association of bisphosphonate use and risk of revision after THA: outcomes from a US total joint replacement registry","volume":"473","author":"Khatod","year":"2015","journal-title":"Clin Orthop Relat Res"},{"issue":"7","key":"2024021014530195000_jbmr3584-bib-0006","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s11999-009-0725-x","article-title":"Case reports: two femoral insufficiency fractures after long- term alendronate therapy","volume":"467","author":"Sayed-Noor","year":"2009","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"2024021014530195000_jbmr3584-bib-0007","doi-asserted-by":"crossref","first-page":"e939","DOI":"10.3928\/01477447-20111021-36","article-title":"Bisphosphonate fractures as a cause of painful total hip arthroplasty","volume":"34","author":"Curtin","year":"2011","journal-title":"Orthopedics"},{"issue":"2","key":"2024021014530195000_jbmr3584-bib-0008","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.2106\/JBJS.CC.K.00085","article-title":"Periprosthetic fracture of the femur after long-term bisphosphonate use","volume":"2","author":"Chen","year":"2012","journal-title":"JBJS Case Connect"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5005\/jp-journals-10017-1021","article-title":"Periprosthetic femoral insufficiency fracture in a patient on long-term bisphosphonate therapy","volume":"2","author":"Schaeffer","year":"2012","journal-title":"Duke Orthopaedic Journal"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13256-015-0590-z","article-title":"Rare non-traumatic periprosthetic femoral fracture with features of an atypical femoral fracture: a case report","volume":"9","author":"Niikura","year":"2015","journal-title":"J Med Case Rep"},{"issue":"7","key":"2024021014530195000_jbmr3584-bib-0011","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1302\/0301-620X.94B7.28778","article-title":"A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture","volume":"94","author":"Cross","year":"2012","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"2024021014530195000_jbmr3584-bib-0012","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/17453674.2015.1036339","article-title":"Bisphosphonate-associated peri-implant fractures: a new clinical entity","volume":"86","author":"Lee","year":"2015","journal-title":"Acta Orthop"},{"key":"2024021014530195000_jbmr3584-bib-0013","first-page":"293","article-title":"Fractures of the femur after hip replacement","volume":"44","author":"Duncan","year":"2005","journal-title":"Instr Course Lect"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5435\/00124635-200401000-00003","article-title":"Periprosthetic femoral fractures above total knee replacements","volume":"12","author":"Su","year":"2004","journal-title":"J Am Acad Orthop Surg"},{"key":"2024021014530195000_jbmr3584-bib-0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00003086-198911000-00003","article-title":"The Knee Society total knee arthroplasty roentgenographic evaluation and scoring system","volume":"248","author":"Ewald","year":"1989","journal-title":"Clin Orthop Relat Res"},{"issue":"4","key":"2024021014530195000_jbmr3584-bib-0016","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/BOT.0000000000000508","article-title":"Periprosthetic atypical femoral fractures in patients on long-term bisphosphonates: a multicenter retrospective review","volume":"30","author":"Robinson","year":"2016","journal-title":"J Orthop Trauma"},{"issue":"6","key":"2024021014530195000_jbmr3584-bib-0017","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1359\/jbmr.081247","article-title":"Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study","volume":"24","author":"Abrahamsen","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2024021014530195000_jbmr3584-bib-0018","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-009-0962-6","article-title":"Fragility fractures of the hip and femur: incidence and patient characteristics","volume":"21","author":"Nieves","year":"2010","journal-title":"Osteoporos Int"},{"issue":"12","key":"2024021014530195000_jbmr3584-bib-0019","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"18","key":"2024021014530195000_jbmr3584-bib-0020","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","article-title":"Bisphosphonate use and atypical fractures of the femoral shaft","volume":"364","author":"Schilcher","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2024021014530195000_jbmr3584-bib-0021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1302\/0301-620X.94B3.27999","article-title":"Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals","volume":"94","author":"Thompson","year":"2012","journal-title":"J Bone Joint Surg Br"},{"issue":"12","key":"2024021014530195000_jbmr3584-bib-0022","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archinternmed.2012.1796","article-title":"Increasing occurrence of atypical femoral fractures associated with bisphosphonate use","volume":"172","author":"Meier","year":"2012","journal-title":"Arch Intern Med"},{"issue":"2","key":"2024021014530195000_jbmr3584-bib-0023","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bone.2010.05.019","article-title":"Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case\/case series studies","volume":"47","author":"Giusti","year":"2010","journal-title":"Bone"},{"issue":"8","key":"2024021014530195000_jbmr3584-bib-0024","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","article-title":"Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis","volume":"28","author":"Gedmintas","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2024021014530195000_jbmr3584-bib-0025","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00198-011-1797-5","article-title":"Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials","volume":"23","author":"Lin","year":"2012","journal-title":"Osteoporos Int"},{"key":"2024021014530195000_jbmr3584-bib-0026","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2106\/JBJS.D.01772","article-title":"Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty","volume":"87","author":"Bhandari","year":"2005","journal-title":"J Bone Joint Surg Am"},{"issue":"10","key":"2024021014530195000_jbmr3584-bib-0027","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1403799","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"371","author":"Schilcher","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"2024021014530195000_jbmr3584-bib-0028","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00774-014-0591-9","article-title":"The incidence of and risk factors for developing atypical femoral fractures in Japan","volume":"33","author":"Saita","year":"2015","journal-title":"J Bone Miner Metab"},{"issue":"19","key":"2024021014530195000_jbmr3584-bib-0029","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"},{"issue":"9","key":"2024021014530195000_jbmr3584-bib-0030","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2165\/00002018-200932090-00002","article-title":"Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital","volume":"32","author":"Ing-Lorenzini","year":"2009","journal-title":"Drug Saf"},{"key":"2024021014530195000_jbmr3584-bib-0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.02.006","article-title":"Symptomatic atypical femoral fractures are related to underlying hip geometry","volume":"63","author":"Taormina","year":"2014","journal-title":"Bone"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0032","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11657-014-0171-6","article-title":"The clinical characteristics of patients with hip fractures in typical locations and atypical femoral fractures","volume":"9","author":"Velasco","year":"2014","journal-title":"Arch Osteoporos"},{"issue":"327","key":"2024021014530195000_jbmr3584-bib-0033","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00003086-199606000-00029","article-title":"Periprosthetic fractures of the femur. An analysis of 93 fractures","author":"Beals","year":"1996","journal-title":"Clin Orthop Relat Res"},{"issue":"6","key":"2024021014530195000_jbmr3584-bib-0034","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.injury.2007.02.049","article-title":"Risk factors for periprosthetic femoral fracture","volume":"38","author":"Franklin","year":"2007","journal-title":"Injury"},{"issue":"7","key":"2024021014530195000_jbmr3584-bib-0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.arth.2005.02.001","article-title":"Periprosthetic femoral fractures: classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register","volume":"20","author":"Lindahl","year":"2005","journal-title":"J Arthroplasty"},{"issue":"6","key":"2024021014530195000_jbmr3584-bib-0036","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.injury.2007.02.048","article-title":"Epidemiology of periprosthetic femur fracture around a total hip arthroplasty","volume":"38","author":"Lindahl","year":"2007","journal-title":"Injury"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0037","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1302\/0301-620X.88B1.17029","article-title":"Risk factors for failure after treatment of a periprosthetic fracture of the femur","volume":"88","author":"Lindahl","year":"2006","journal-title":"J Bone Joint Surg Br"},{"issue":"12","key":"2024021014530195000_jbmr3584-bib-0038","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1007\/s11999-010-1535-x","article-title":"Femoral insufficiency fractures associated with prolonged bisphosphonate therapy","volume":"468","author":"Isaacs","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"2024021014530195000_jbmr3584-bib-0039","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bone.2015.10.016","article-title":"Assessment of femur geometrical parameters using EOS\u2122 imaging technology in patients with atypical femur fractures; preliminary results","volume":"83","author":"Morin","year":"2016","journal-title":"Bone"},{"issue":"4","key":"2024021014530195000_jbmr3584-bib-0040","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00776-014-0572-9","article-title":"Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series","volume":"19","author":"Oh","year":"2014","journal-title":"J Orthop Sci"},{"issue":"11","key":"2024021014530195000_jbmr3584-bib-0041","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.injury.2014.08.037","article-title":"Potential pathogenic mechanism for stress fractures of the bowed femoral shaft in the elderly: mechanical analysis by the CT-based finite element method","volume":"45","author":"Oh","year":"2014","journal-title":"Injury"},{"issue":"5","key":"2024021014530195000_jbmr3584-bib-0042","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s00774-012-0358-0","article-title":"Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series","volume":"30","author":"Sasaki","year":"2012","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"2024021014530195000_jbmr3584-bib-0043","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1302\/0301-620X.89B3.18146","article-title":"Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution","volume":"89","author":"Goh","year":"2007","journal-title":"J Bone Joint Surg Br"},{"issue":"5","key":"2024021014530195000_jbmr3584-bib-0044","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"issue":"2","key":"2024021014530195000_jbmr3584-bib-0045","first-page":"77","article-title":"Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology","volume":"52","author":"Koh","year":"2011","journal-title":"Singapore Med J"},{"issue":"6","key":"2024021014530195000_jbmr3584-bib-0046","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/17453674.2013.866193","article-title":"Dichotomous location of 160 atypical femoral fractures","volume":"84","author":"Koeppen","year":"2013","journal-title":"Acta Orthop"},{"issue":"1","key":"2024021014530195000_jbmr3584-bib-0047","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11999-011-1985-9","article-title":"The effect of long-term alendronate treatment on cortical thickness of the proximal femur","volume":"470","author":"Unnanuntana","year":"2012","journal-title":"Clin Orthop Relat Res"},{"issue":"12","key":"2024021014530195000_jbmr3584-bib-0048","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/jbmr.157","article-title":"A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover","volume":"25","author":"Burghardt","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2024021014530195000_jbmr3584-bib-0049","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jbmr.2345","article-title":"Cortical thickness of the femur and long-term bisphosphonate use","volume":"30","author":"Niimi","year":"2015","journal-title":"J Bone Miner Res"},{"key":"2024021014530195000_jbmr3584-bib-0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bone.2014.01.011","article-title":"Absence of femoral cortical thickening in long-term bisphosphonate users: implications for atypical femur fractures","volume":"62","author":"Chen","year":"2014","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjbmr.3584","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.3584","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.3584","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/1\/83\/56655522\/jbmr3584.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/34\/1\/83\/56655522\/jbmr3584.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T15:02:42Z","timestamp":1710342162000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/34\/1\/83-92\/7605974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,2]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,10,2]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.3584","relation":{},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1,1]]},"published":{"date-parts":[[2018,10,2]]},"assertion":[{"value":"2018-03-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-26","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}